Cancer Experience Registry (CER) for Cancer Patients and Caregivers
Launched by CANCER SUPPORT COMMUNITY, RESEARCH AND TRAINING INSTITUTE, PHILADELPHIA · Jan 6, 2015
Trial Information
Current as of August 20, 2025
Recruiting
Keywords
ClinConnect Summary
The Cancer Experience Registry (CER) is an online study designed to learn more about the experiences of people affected by cancer, including patients and their caregivers. The study collects information through surveys that ask about various aspects of living with cancer, such as emotional challenges, physical health, financial concerns, and the decision-making process. By gathering this information, the researchers hope to improve care and support for cancer patients and their families in the future.
To participate in this study, you should have been diagnosed with cancer or be a caregiver for someone who has. Caregivers can be family members or friends who help support someone with cancer. This study is open to adults aged 65 and older living in the United States, its territories, or Canada, who can read and understand English. There are no specific exclusions, so if you meet the criteria, you are welcome to join. As a participant, you can expect to fill out surveys that reflect your experiences, and your responses will help shape future cancer care and support programs.
Gender
ALL
Eligibility criteria
- Inclusion criteria:
- • Have received a cancer diagnosis or have been a family caregiver or informal caregiver (i.e., a relative or friend) for someone diagnosed with cancer
- • Live in United States, a US territory, or Canada
- • Able to read and understand English
- Exclusion criteria:
- • None
About Cancer Support Community, Research And Training Institute, Philadelphia
The Cancer Support Community Research and Training Institute, based in Philadelphia, is a leading organization dedicated to improving the quality of life for individuals affected by cancer through research, education, and support. As a clinical trial sponsor, the Institute focuses on advancing the understanding of psychosocial aspects of cancer care, promoting evidence-based interventions, and fostering collaboration among healthcare professionals. With a commitment to empowering patients and their families, the Institute conducts innovative studies aimed at enhancing access to comprehensive support services and improving health outcomes for the cancer community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Philadelphia, Pennsylvania, United States
Washington, District Of Columbia, United States
Patients applied
Trial Officials
Erica E. Fortune, PhD
Principal Investigator
Cancer Support Community
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials